Mesothelioma News.

Mesothelioma: Questions and Answers - National Cancer Institute

Comprehensive information site on mesothelioma diagnosis, treatment, coping, asbestos disease and financial assistance.

What Is Mesothelioma?

By Anonymous

June 24, 2004 -- Mesothelioma is still a relatively rare form of cancer. There are an estimated 2,000 - 3,000 new cases per year in the United States. Approximately 7-13 per one million male patients with a history of asbestos exposure contract mesothelioma. Diagnosis usually occurs 20-40 years after initial exposure to asbestos. For these reasons, it is important for American males to understand the basics of this disease.

The Mesothelioma Reporter has announced the launch of a special report, “What Is Mesothelioma?”. The report is available online at http://www.mesotheliomareporter.org/2004/03/what_is_mesothe.html at no cost. The information within explains the basics of pleural mesothelioma, peritoneal mesothelioma, and pericardial mesothelioma, and describes the symptoms related to this asbestos-related disease.

The guide was edited by Jimmy Atkinson of The Mesothelioma Reporter ( http://www.mesotheliomareporter.org ). “Mesothelioma is a deadly disease, so if someone has asbestos exposure-related symptoms, it is important that they understand the importance of seeking medical help quickly,” said Atkinson.

Jimandi Corp is a privately held company based in Los Angeles, California. For more information, please visit http://www.dotmarketer.com . Visit The Mesothelioma Reporter at http://www.mesotheliomareporter.org or view the report at http://www.mesotheliomareporter.org/2004/03/what_is_mesothe.html .



This article courtesy of http://texasmesotheliomareview.info/.
You may freely reprint this article on your website or in
your newsletter provided this courtesy notice and the author
name and URL remain intact.

MesotheliomaHQ.com has been nominated for the Charles Ingood Award of Excellence

By Anonymous

September 25, 2004 -- In 2003, a small group of people came together to start a new informational resource for cancer patients suffering from mesothelioma. This group had a vision of extending the capabilities of the normal mesothelioma website in order to provide a better experience beyond the normal cancer website. Within one year this vision has developed into a mesothelioma website with a national following providing an extensive suite of mesothelioma information solutions with a focus on the patient and their family's need.

In recognition of this success, the Web site http://www.mesotheliomahq.com has been nominated for the Charles Ingood Award of Excellence. This prestigious award recognizes the accomplishments in the area of medical support.

With over a 220% growth in users since the launch of MesotheliomaHQ.com in 2003, the growth has exceeded expectations. MesotheliomaHQ.com is now planning to expand their capabilities and will be announcing changes very soon.

The Charles Ingood Award of Excellence was started in 1998 to highlight different supporters of the medicinal process. It is awarded once a year to a person or organization that has proven to be a superior provider of a supporting service or informational resource on any medical field ranging from cancer, childcare and now with this nomination - mesothelioma.

About MesotheliomaHQ.com:
Founded in 2003, MesotheliomaHQ.com created a new layout and information gathering method that significantly increased the available mesothelioma information available today. MesotheliomaHQ.com's goal is to provide the best experience for all people seeking information about mesothelioma treatment, legal information and general information regarding mesothelioma. MesotheliomaHQ.com is headquartered in New York, NY. More information on this nomination can be found on the Web site, Mesothelioma HQ ( http://www.mesotheliomahq.com ) An example of the nominated material can be found in the mesothelioma treatment section (http://www.mesotheliomahq.com/mesothelioma_treatment.html).



This article courtesy of http://texasmesotheliomareview.info/.
You may freely reprint this article on your website or in
your newsletter provided this courtesy notice and the author
name and URL remain intact.

New blood test for mesothelioma developed.

By Anonymous

September 17, 2004 -- Scientists have developed a relatively simple blood test for mesothelioma, a highly aggressive lung cancer caused by asbestos exposure. The Mesothelioma Web, http://www.1mesothelioma-treatment.org/, has information on diagnosis and treatment of mesothelioma.

Mesothelioma has traditionally be a difficult diagnosis. Although general practitioners and internists sometimes make the diagnosis, they almost always refer patients to oncologists for a confirming diagnosis and for treatment. Oncologists sometimes further refer patients to doctors who specialize in mesothelioma. The treatment program for mesothelioma depends on many factors, including: the stage of the cancer, where the cancer is, how far the cancer has spread, how the cancer cells look under the microscope and the patient’s age and desires.

The oldest staging system and the one most often used is the Butchart System which is based mainly on the extent of primary tumor mass and divides mesotheliomas into four stages. The more recent TNM system considers variables of tumor in mass and spread, lymph node involvement, and metastasis. The Brigham System is the latest system and stages mesothelioma according to resectability (the ability to surgically remove) and lymph node involvement.

Butchart System – extent of primary tumor mass
- Stage I: Mesothelioma is present in the right or left pleura and may also involve the diaphragm on the same side.
- Stage II: Mesothelioma invades the chest wall or involves the esophagus, heart, or pleura on both sides. Lymph nodes in the chest may also be involved.
- Stage III: Mesothelioma has penetrated through the diaphragm into the lining of the abdominal cavity or peritoneum. Lymph nodes beyond those in the chest may also be involved.
- Stage IV: There is evidence of metastasis or spread through the bloodstream to other organs.

TNM System -- variables of T (tumor), N (lymph nodes), M (metastasis)
- Stage I: Mesothelioma involves right or left pleura and may also have spread to the lung, pericardium, or diaphragm on the same side. Lymph nodes are not involved.
- Stage II: Mesothelioma has spread from the pleura on one side to nearby lymph nodes next to the lung on the same side. It may also have spread into the lung, pericardium, or diaphragm on the same side.
- Stage III: Mesothelioma is now in the chest wall, muscle, ribs, heart, esophagus, or other organs in the chest on the same side with or without spread to lymph nodes on the same side as the primary tumor.
- Stage IV: Mesothelioma has spread into the lymph nodes in the chest on the side opposite the primary tumor, or extends to the pleura or lung on the opposite side, or directly extends into organs in the abdominal cavity or neck. Any distant metastases is included in this stage.

Brigham System: (variables of tumor resectability and nodal status)
- Stage I: Resectable mesothelioma and no lymph node involvement
- Stage II: Resectable mesothelioma but with lymph node involvement
- Stage III: Unresectable mesothelioma extending into chest wall, heart, or through diaphragm, peritoneum; with or without extrathoracic lymph node involvement
- Stage IV: Distant metastatic disease

The Mesothelioma Web, http://www.1mesothelioma-treatment.org , is the Internet’s best resource for diagnosis and treatment of mesothelioma, a form of cancer cause by asbestos exposure.




This article courtesy of http://texasmesotheliomareview.info/.
You may freely reprint this article on your website or in
your newsletter provided this courtesy notice and the author
name and URL remain intact.